Initial Immune Response Tied to Radiosensitivity in TNBC

In triple-negative breast cancer, initially immune-enriched tumors with residual disease after neoadjuvant therapy may be more resistant to radiotherapy. Medscape Medical News

Read the full article on medscape.com